Depomed names new CEO

March 28 (Reuters) - Drugmaker Depomed Inc, which has been facing pressure from activist investor Starboard Value LP, named a new chief executive officer and said it would add three new directors to its board.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.